Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

Conditions: HER2-positive Metastatic Breast Cancer Interventions: Drug: inetetamab Sponsors: Liaoning Tumor Hospital& Institute Completed

Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials